Recent Updates
Recently added Catalysts
LMAT Positive Sentiment

LeMaitre to Participate in Upcoming Investor Conferences

Wednesday, November 12, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: LeMaitre Vascular, Inc. has announced its participation in three upcoming investor conferences. CFO Dorian LeBlanc will present at the Jefferies London Healthcare Conference and the Piper Sandler 37th Annual Healthcare Conference, while President David Roberts will present at the Wolfe Research 7th Annual Healthcare Conference. These events aim to enhance investor relations and showcase the company's offerings in peripheral vascular disease treatment.
Price reaction · baseline $89.97 (2025-11-12 close) · hit after-hours · clean, no other LMAT news in the window
day 0 close · peak
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in multiple investor conferences demonstrates company engagement.
  • Leadership presentations can enhance investor relations and visibility.
  • Focus on peripheral vascular disease highlights the company's commitment to addressing significant health issues.

Full Press Release Details

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

Jefferies London Healthcare Conference 2025

Tuesday, November 18, 2025Waldorf Hilton, LondonDorian LeBlanc, CFO, will present at 8:00 AM GMT

Wolfe Research 7th Annual Healthcare Conference

Wednesday, November 19, 2025Wolfe NYC Offices, New York, NYDavid Roberts, President, will present at 10:40 AM ET

Piper Sandler 37thAnnual Healthcare Conference

Thursday, December 4, 2025Lotte Palace, New York, NYDorian LeBlanc, CFO, will present at 3:20 PM ET

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visitwww.lemaitre.com.
LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Frequently Asked Questions

Which conferences will LeMaitre participate in?

LeMaitre will participate in the Jefferies London Healthcare Conference, Wolfe Research 7th Annual Healthcare Conference, and Piper Sandler 37th Annual Healthcare Conference.

Who will present at the Jefferies Conference?

Dorian LeBlanc, the CFO, will present at the Jefferies London Healthcare Conference.

When is the Piper Sandler Conference?

The Piper Sandler 37th Annual Healthcare Conference is scheduled for December 4, 2025.

What is LeMaitre's focus area?

LeMaitre focuses on devices and services for treating peripheral vascular disease.

ShareAdd on Google
Tags: LMAT Viatris Investor Conferences Healthcare LeMaitre Vascular investor conferences healthcare vascular disease
Last updated: Nov 12, 2025

Biotech snapshot

Cash runway
$376M liquidity · $0M/mo burn
Low dilution risk